Author(s): Duffield S.J.; Ellis B.M.; Loftis T.; Goodson N.; Walker-Bone K.; Conaghan P.G.; Margham T.
Source: Best Practice and Research: Clinical Rheumatology; 2017
Publication Date: 2017
Publication Type(s): Article In Press
Available at Best practice & research. Clinical rheumatology – from ScienceDirect
Available at Best practice & research. Clinical rheumatology – from ScienceDirect
Available at Best practice & research. Clinical rheumatology – from Edge Hill Aintree LIRC (lib302411) Local Print Collection [location] : Edge Hill Aintree LIRC.
Abstract:People frequently live for many years with multiple chronic conditions (multimorbidity) that impair health outcomes and are expensive to manage. Multimorbidity has been shown to reduce quality of life and increase mortality. People with multimorbidity also rely more heavily on health and care services and have poorer work outcomes. Musculoskeletal disorders (MSDs) are ubiquitous in multimorbidity because of their high prevalence, shared risk factors, and shared pathogenic processes amongst other long-term conditions. Additionally, these conditions significantly contribute to the total impact of multimorbidity, having been shown to reduce quality of life, increase work disability, and increase treatment burden and healthcare costs. For people living with multimorbidity, MSDs could impair the ability to cope and maintain health and independence, leading to precipitous physical and social decline. Recognition, by health professionals, policymakers, non-profit organisations, and research funders, of the impact of musculoskeletal health in multimorbidity is essential when planning support for people living with multimorbidity.
Copyright © 2017 The Authors.
Database: EMBASE